
    
      Adult fifty patient with chronic renal failure on hemodialysis, scheduled for arteriovenous
      fistula creation under ultrasound guided supraclavicular block. Patients were randomly
      allocated in two group. The articaine group (group A) received 40 ml articaine hydrochloride
      2% and articaine-dexmedetomidine group (group AD) received 40 ml. Of articaine 2% mixed with
      dexmedetomidine (1micogram/kg)
    
  